tiopronin has been researched along with Carcinoma, Transitional Cell in 1 studies
Tiopronin: Sulfhydryl acylated derivative of GLYCINE.
Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwamoto, Y | 1 |
| Kuroiwa, T | 1 |
| Aoki, K | 1 |
| Baba, T | 1 |
1 other study available for tiopronin and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
"Two-route chemotherapy" using high-dose intra-arterial neocarzinostatin and systemic tiopronin, its antidote, for rat limb tumor.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marrow; Carcinoma, Transi | 1986 |